Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

48.06
Delayed Data
As of Jul 29
 +0.69 / +1.46%
Today’s Change
26.02
Today|||52-Week Range
49.66
+7.09%
Year-to-Date
Seattle Genetics, Inc. Making the Most of It (and Then Some)
Jul 29 / MotleyFool.com - Paid Partner Content
What's in Store for these 5 Drug Stocks in Q2 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
Barbarian At The Gate: Seattle Genetics (SGEN)
Jul 27 / TheStreet.com - Paid Partner Content
3 Stocks We're Buying Again
Jul 21 / MotleyFool.com - Paid Partner Content
Seattle Genetics' (SGEN) Loss Narrower than Expected in Q2
Jul 27 / Zacks.com - Paid Partner Content
3 Primary Ways Researchers Are Combatting Cancer
Jul 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close47.37
Today’s open47.20
Day’s range46.32 - 48.07
Volume652,361
Average volume (3 months)883,041
Market cap$6.7B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-9.61%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book9.77

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc0.000.00%
RDYDr.Reddy's Laborator...+0.04+0.09%
TAROTaro Pharmaceutical ...+0.02+0.01%
ALNYAlnylam Pharmaceutic...-0.21-0.31%
Data as of 4:02pm ET, 07/29/2016

Financials

Last reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

Partner Offers

Search for Jobs